BC Week In Review | Feb 4, 2013
Company News

AmorChem, McGill University, Florida Institute of Technology deal

Life science VC fund AmorChem and the universities partnered to develop 5-oxo-ETE receptor antagonists to treat eosinophilic disorders, including severe asthma. AmorChem said the deal will target the "animal proof of concept" of the compounds....
Items per page:
1 - 1 of 1